- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Caprius enters diagnostics market
Caprius of Fort Lee, NJ, completed its exit from the medical imaging field by acquiring an in vitro diagnostics company in late June. Caprius announced that it had acquired Opus Diagnostics and intends to market a line of therapeutic drug monitoring
Caprius of Fort Lee, NJ, completed its exit from the medical imaging field by acquiring an in vitro diagnostics company in late June. Caprius announced that it had acquired Opus Diagnostics and intends to market a line of therapeutic drug monitoring products. Caprius previously marketed the Aurora breast MRI scanner until it sold that business in April to Pacific Republic Capital of Newport Beach, CA (SCAN 5/12/99). As part of the deal, several Opus executives have been appointed to lead Caprius. Caprius long-time chairman and CEO, Jack Nelson, will be leaving the company, as will president Enrique Levy.
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.
